secwatch.observer — SEC 8-K summary
======================================

Issuer:     Verrica Pharmaceuticals Inc. (VRCA)
CIK:        0001660334
Form:       8-K
Filed at:   2023-02-21T23:59:59+00:00
Accession:  0001193125-23-043040
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Verrica prices $32.5M underwritten offering of common stock and pre-funded warrants
--------------------------------------------------------------------------------

- 750,000 shares at $6.75 and 4,064,814 pre-funded warrants at $6.7499 per share.
- Gross proceeds expected ~$32.5M before underwriting discounts and expenses.
- Jefferies LLC acting as sole book-runner; closing expected Feb 23, 2023.
- Offering substantially led by one healthcare dedicated fund.
- Shelf registration statement (333-268229) effective Dec 19, 2022.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1660334/000119312523043040/0001193125-23-043040-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1660334/000119312523043040/d464394d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-043040

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer